CLC number:
On-line Access: 2023-03-10
Received: 2022-08-29
Revision Accepted: 2022-12-21
Crosschecked: 2023-03-13
Cited: 0
Clicked: 1066
Citations: Bibtex RefMan EndNote GB/T7714
Xinyan WANG, Xiuling XU, Ting ZHANG, Yang JIN, Sheng XU, Lifeng CHEN, Yucheng LAI, Ling ZHANG, Ruolang PAN, Yan YU. Estrogen upregulates DNA2 expression through the PI3K-AKT pathway in endometrial carcinoma[J]. Journal of Zhejiang University Science B, 2023, 24(3): 262-268.
@article{title="Estrogen upregulates DNA2 expression through the PI3K-AKT pathway in endometrial carcinoma",
author="Xinyan WANG, Xiuling XU, Ting ZHANG, Yang JIN, Sheng XU, Lifeng CHEN, Yucheng LAI, Ling ZHANG, Ruolang PAN, Yan YU",
journal="Journal of Zhejiang University Science B",
volume="24",
number="3",
pages="262-268",
year="2023",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2200436"
}
%0 Journal Article
%T Estrogen upregulates DNA2 expression through the PI3K-AKT pathway in endometrial carcinoma
%A Xinyan WANG
%A Xiuling XU
%A Ting ZHANG
%A Yang JIN
%A Sheng XU
%A Lifeng CHEN
%A Yucheng LAI
%A Ling ZHANG
%A Ruolang PAN
%A Yan YU
%J Journal of Zhejiang University SCIENCE B
%V 24
%N 3
%P 262-268
%@ 1673-1581
%D 2023
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2200436
TY - JOUR
T1 - Estrogen upregulates DNA2 expression through the PI3K-AKT pathway in endometrial carcinoma
A1 - Xinyan WANG
A1 - Xiuling XU
A1 - Ting ZHANG
A1 - Yang JIN
A1 - Sheng XU
A1 - Lifeng CHEN
A1 - Yucheng LAI
A1 - Ling ZHANG
A1 - Ruolang PAN
A1 - Yan YU
J0 - Journal of Zhejiang University Science B
VL - 24
IS - 3
SP - 262
EP - 268
%@ 1673-1581
Y1 - 2023
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2200436
Abstract: endometrial cancer is the most common gynecological malignancy, affecting up to 3% of women at some point during their lifetime (
[1]BeanJR, HosfordSR, SymondsLK, et al., 2015. The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer. Breast Cancer Res Treat, 149(1):69-79.
[2]ConstantineGD, KesslerG, GrahamS, et al., 2019. Increased incidence of endometrial cancer following the women’s health initiative: an assessment of risk factors. J Womens Health (Larchmt), 28(2):237-243.
[3]DuanL, CalhounS, ShimD, et al., 2021. Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells. J Mol Cell Biol, 13(6):433-444.
[4]GaoCX, ShiJM, ZhangJX, et al., 2022. Chemerin promotes proliferation and migration of ovarian cancer cells by upregulating expression of PD-L1. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(2):164-170.
[5]HanYY, ZhangZY, WangZ, et al., 2021. Increased expression of DNA2 was linked to poor prognosis in breast cancer. Dis Markers, 2021:8860728.
[6]HassonSP, RubinekT, RyvoL, et al., 2013. Endocrine resist
[7]ance in breast cancer: focus on the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway. Breast Care (Basel), 8(4):248-255.
[8]JiaPP, JunaidM, MaYB, et al., 2017. Role of human DNA2 (hDNA2) as a potential target for cancer and other diseases: a systematic review. DNA Repair (Amst), 59:9-19.
[9]LiCH, WangCH, 2021. LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(8):633-646.
[10]LuoJ, SongZM, ZhangT, et al., 2022. Upregulation of h-TERT and Ki-67 in ectopic endometrium is associated with recurrence of endometriosis. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 23(2):158-163.
[11]MoriceP, LearyA, CreutzbergC, et al., 2016. Endometrial cancer. Lancet, 387(10023):1094-1108.
[12]SetiawanVW, YangHP, PikeMC, et al., 2013. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol, 31(20):2607-2618.
[13]StraussC, KornowskiM, BenvenistyA, et al., 2014. The DNA2 nuclease/helicase is an estrogen-dependent gene mutated in breast and ovarian cancers. Oncotarget, 5(19):9396-9409.
[14]ThakarT, LeungW, NicolaeCM, et al., 2020. Ubiquitinated-PCNA protects replication forks from DNA2-mediated degradation by regulating Okazaki fragment maturation and chromatin assembly. Nat Commun, 11:2147.
[15]UlrichLSG, 2011. Endometrial cancer, types, prognosis, female hormones and antihormones. Climacteric, 14(4):418-425.
[16]VassardD, SchmidtL, GlazerCH, et al., 2019. Assisted reproductive technology treatment and risk of ovarian cancer—a nationwide population-based cohort study. Hum Reprod, 34(11):2290-2296.
[17]ZhengL, ZhouM, GuoZG, et al., 2008. Human DNA2 is a mitochondrial nuclease/helicase for efficient processing of DNA replication and repair intermediates. Mol Cell, 32(3):325-336.
Open peer comments: Debate/Discuss/Question/Opinion
<1>